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Using a ChIP-cloning technique, we identified a Zinc finger protein 804a (Zfp804a) as one of the putative Hoxc8 downstream target
genes. We confirmed binding of Hoxc8 to an intronic region of Zfp804a by ChIP-PCR in F9 cells as well as in mouse embryos.
Hoxc8 upregulated Zfp804a mRNA levels and augmented minimal promoter activity in vitro. In E11.5 mouse embryos, Zfp804a
and Hoxc8 were coexpressed. Recent genome-wide studies identified Zfp804a (or ZNF804A in humans) as a plausible marker for
schizophrenia, leading us to hypothesize that this embryogenic regulatory control might also exert influence in development of
complex traits such as psychosis.
1. Introduction
Hox genes encode transcription factors containing a 61-
amino acid motif that enables binding and transcriptional
regulation of target gene expression [1–3]. The mam-
malian Hox genes have 39 members organized in four
clusters (HoxA-D) each located on a diﬀerent chromosome.
Resulting from successive duplications during the evolu-
tion of an ancestral Hox complex, each cluster contains
a series of paralogues (groups I–XIII). Each Hox gene
has a conserved helix-turn-helix DNA-binding domain
that recognizes and binds to specific sequence motifs
(TAAT/ATTA/TTAT/ATAA) located in promoter sequences,
intergenic and intronic regions. Such conserved sequence
motif is also found repeatedly several times in the genome
underscoring a potentially expansive regulatory landscape
of Hox genes [4, 5]. Hox expression domains along the
anterior-posterior (A-P) axis is characterized as overlapping,
with the order and timing of expression correlating to
the position of genes along a cluster. The combinatorial
expression of various Hox genes constitutes the proverbial
“Hox code”: the genetic program that determines cell
fates, that is, morphogenesis, growth, and diﬀerentiation
during embryonic development [6]. Meanwhile, in adult
cells, Hox genes assume some poorly understood oncogenic
roles. For example, expression of HOXC5 and HOXC8 is
selectively elevated in human cervical cancer cells when
compared to normal keratinocytes [7]. In human prostate
adenocarcinomas, HOXC8 expression is directly correlated
with the loss of tumor diﬀerentiation based on Gleason
scoring [8]. Moreover, Hox genes have been ascribed with
“nonconventional” roles such as postnatal neuronal circuit
development [9] although data is still scant.
To gain better understanding of the mechanisms by
which Hox functions during mouse embryogenesis, the
identification and functional analysis of target genes are
necessary. In this study, we focused our analysis on the
downstream targets of Hoxc8, one of three members of
the paralogous group VIII, which our group and other
laboratories have extensively studied in the past years [6, 10–
13]. Several molecular tools have allowed us to identify
the developmental regulatory targets of Hoxc8 in a high-
throughput manner. Microarray expression analysis by the
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group of Frank Ruddle has identified 34 genes involved
in cell adhesion, migration, metabolism, and apoptosis
whose expression levels were diﬀerentially changed in mouse
embryonic cells overexpressing Hoxc8 [6]. Likewise, our
group identified, using proteomics, 15 genes associated with
cell motility, protein homeostasis, and metabolism [14].
More recently, modified chromatin immunoprecipitation-
(ChIP-) based methods have been developed, such as ChIP-
cloning, ChIP Display, Diﬀerential Chromatin Scanning,
and ChIP-chip and DamID chromatin profiling, permitting
the screening for DNA-protein interaction in vivo at a
genome-wide scale [15]. We took advantage of a ChIP-
cloning gene discovery strategy [16] to search for novel
downstream target genes of Hoxc8 that may be important
during mouse development. We identified 12 putative target
sites by ChIP-cloning and subjected these to comparative
genomics analysis to identify Hoxc8-binding motifs that
are conserved across the mammalian lineage leading to the
identification of Zfp804a, as a strong candidate target. We
further confirm the regulation of Zfp804a by ChIP-PCR,
coexpression analysis and a reporter assay.
2. Materials and Methods
2.1. Animal Preparation. In order to get E11.5 embryos, ICR
mice were allowed to mate at 6:00 pm, and presence of a
vaginal plug in the following morning indicates the 0.5 day
post coitum (dpc) time point. After 11 days, the pregnant
mice were sacrificed and E11.5 embryos were taken. Maternal
and extraembryonic tissues were removed.
2.2. Cell Culture and Transfection. F9 cells were cultured in
DMEM media supplemented with 10% of fetal bovine serum
(FBS) and 100 μg/ml penicillin-streptomycin (Invitrogen,
Carlsbad, CA, USA) in plates that were coated with 0.1%
gelatin. The cells were incubated at 37◦C in a 5% CO2 envi-
ronment. In 100 mm dishes, upon reaching ∼50%, the cells
were transfected with 4 μg of pcDNA3 (empty vector control)
or pcDNA3:Hoxc8 plasmid DNA using Lipofectamine 2000
system (Invitrogen).
2.3. ChIP Assays. ChIP assays were performed on fresh E11.5
embryos with the head and internal organs removed using a
ChIP assay kit (Upstate Biotechnolgy, Lake Placid, NY, USA)
with slight modification. To enrich specificity, immuno-
precipitation step was performed thrice using a Hoxc8-
monoclonal antibody (MMS-266R, Covance Research prod-
ucts, Princeton, NJ, USA). Immunoprecipitation in the
absence of the antibody served as negative control. ChIP-
DNA was cloned into pBluescriptII SK(+) vector and its
inserts were sequenced [17]. We reported our identification
of Hoxc8 gene targets using this ChIP-cloning protocol in our
previous paper [10].
In order to verify whether the identified genes are a target
of Hoxc8, we PCR-amplified fragments from ChIP-DNA of
E11.5 embryos and F9 cells using the primers F, 5′ggagtc-
acaaccaaatctgc 3′ and R, 5′cagggaattttgggcattat 3′. PCR was
carried out with a 5-minute hot start at 94◦C, followed by
33 cycles of denaturation (94◦C for 1 minute), annealing
(1 minute at 55◦C), and extension (1 minute at 72◦C).
2.4. RNA Isolation and RT-PCR. Total cellular RNA was
extracted with RNAzol Bee (Tel-test, Inc. Industries Inc.,
Texas, USA), partitioned with chloroform/isoamyl alcohol
and centrifuged at 12 000 rpm at 4◦C for 15 minutes.
RNA was precipitated by adding equal volume of cold iso-
propanol and centrifugation at 12 000 rpm at 4◦C for 15
minutes. Pellet was washed with 70% ethanol, air-dried,
and resuspended in DEPC-H2O. RT-PCR was performed
on 2 μg of the RNA with the following PCR conditions: 5
minutes hot start at 94◦C, followed by denaturation at 94◦C
for 1 minute, annealing step at the specific temperatures
for 50 seconds (β-actin, 56◦C, Hoxc8, 56◦C, and Zfp804a,
55◦C), and extension step at 72◦C for 1 minute for 28
cycles. Each reaction was terminated after a final elongation
step of 72◦C for 7 minutes. The sequences of the primers
were as follows: β-actin (F, 5′catgtttgagaccttcaacacccc 3′;
R, 5′gccatctcctgctcgaagtctag3′), Hoxc8 (F, 5′cctattacgact-
gccggttc3′; R, 5′ttggcggaggatttacagtc 3′), and Zfp804a (F,
5′tcacaagggacccatcaaat3′; R, 5′ttagcatgttcggctgaatg 3′).
2.5. Eﬀector-Reporter Assay. An eﬀector-reporter assay was
done using the Dual-Luciferase Reporter Assay System
(Promega, Madison, WI, USA). Zfp804a gene fragment was
cloned into the pGL3MP vector [18] to make the eﬀector-
reporter construct. For the luciferase assay, 2 × 105 F9
cells/well were seeded into a 6-well plate and cultured
until 50% of confluency. Four micrograms of eﬀector
(pcDNA3:Hoxc8; pcDNA3:Hoxc8 +siHoxc8) were cotrans-
fected in the cells with 1 μg of the reporter (pGL3-MP; pGL2-
MP:Zfp804a) and 25 ng of pRL-TK vectors. After 36 hours,
the cells were lysed and luciferase activity was measured using
the GLOMAX 20/20 luminometer (Promega).
3. Results and Discussion
Hox genes play a role as a “realisator” of body pattern
formation [2, 3]. Since the discovery of Drosophila Hox genes
in the early 1980s, there has been an avalanche of studies
on their roles in mammalian development. However, while
much is already known about Hox gene structure and its
function, how it determines the precise formation of the
body parts along the A-P axis is still enigmatic. In order
to gain further insight into the molecular basis of how
various Hox genes control tissue fate, it is necessary that their
downstream genes are identified and characterized.
We obtained target genes of Hoxc8 by ChIP-cloning [10]
and further demonstrated regulation of a candidate gene.
ChIP-cloning approach is a modification of the ChIP assay
which combines immunoprecipitation of sheared chromatin
with subsequent DNA cloning and sequencing (Figure 1).
In our ChIP-cloning procedures, we used E11.5 mouse
embryos because Hoxc8 expression is relatively elevated at
this particular stage compared to other time points [10].
After removal of the head and internal organs, the embryo
was fixed with formaldehyde to cross-link DNA-protein
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interactions. After the DNA complexes were pulled down by
an anti-Hoxc8 monoclonal antibody, purified ChIPed DNA
fragments were cloned and sequenced. Out of 146 clones,
we identified 12 candidate genes from 16 sequences, most
of which contained Hox-binding motifs (see Table 1). As it
is logical to assume that Hox-binding will likely occur in
the promoter regions of its target genes, in our experiment,
all our cloned DNA fragments were derived from intronic
and intergenic regions. A similar observation was reported
by Birkaya et al. [19] showing that >40% of DeltaNp63-
ChIP fragments were from the introns. One of the cloned
regions of our candidate targets, calpain 10 (NM 011796.2),
does not have a Hox-binding motif implying that if this
was confirmed as true target, Hoxc8 may likely regulate the
gene via indirect binding, probably in collaboration with a
cofactor(s), as in the case of TGF-β signaling with Hoxc8
[20–22]. Among the candidate genes, we chose to study zinc
finger protein 804a (Zfp804a; NM 175513) since this cloned
intronic region contains ∼8.4 Hox-binding sites per 100 bp.
In subsequent in silico analysis, however, out of the 75 Hox-
binding motifs present, only 4 were conserved across a wide
range of mammalian species: human, chimpanzee, rhesus,
orangutan, marmoset, cat, horse, dog, opossum, mouse, rat,
and guinea pig.
To further demonstrate Zfp804a-Hoxc8-binding, we val-
idated the interaction by performing ChIP-PCR on cell
extracts from Hoxc8-overexpressing F9 murine embryonic
teratocarcinoma cell line (in vitro) and E11.5 mouse embryos
(in vivo). Located in chromosome 2, the Zfp804a gene
contains 4 coding exons with a noncontiguous string of
Hoxc8-binding motifs within its first intron. We designed
primers to target the area where putative Hox-binding
sites are abundant (Figure 2(a)). Zfp804a gene was clearly
amplified from the DNA samples that had been precipitated
by a commercial monoclonal (Figure 2(b)) and an in-
house polyclonal antibody (data not shown) but not by an
antimouse IgG. The strongest band of Zfp804a among 12
candidate genes in ChIP-PCR led us to focus our analysis
on it (data not shown). The Zfp804a band was also detected
from input lane which served as the internal control. Our
results, therefore, indicate that the Hoxc8 protein stably and
directly binds to the first intron of Zfp804a.
Does this binding lead to a modulation of gene expres-
sion? Given the fact that the regulation of Zfp804a is
largely unknown, we utilized an unbiased eﬀector-reporter
assay by cloning the Zfp804a intronic fragment into the
minimal promoter plasmid, pGL3-MP (pGL3-MP:Zfp804a).
With transfection into F9 cells and assaying for dual-
luciferase activity after 36 hours, enhancement of pro-
moter activity relative to pGL3-MP was seen when Hoxc8
expression plasmid was cotransfected compared with the
empty vector (pcDNA3 alone). In addition, we were able
to demonstrate that the augmented promoter activity was
abolished by adding Hoxc8 siRNA (Figure 2(c)). These
data suggest that the intronic fragment of Zfp804a may
function as an alternative promoter, and the modulation
of activity of the minimal promoter [18] by such intronic
sequence endorses the functionality of the Hoxc8-Zfp804a
interaction.
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Figure 1: ChIP-cloning flow chart. The procedure of ChIP methods
is based on Upstate manufacture’s instructions. The embryos
(E11.5) and F9 cells were prepared for ChIP-cloning as detailed
above.
Finally, we studied whether Hoxc8 modulates expression
of Zfp804a. For this, we transiently transfected with a
Hoxc8 overexpression construct F9 cells having undetectable
levels of Hoxc8 and Zfp804a mRNAs. Compared with
the empty vector control, the cells overexpressing Hoxc8
showed induction of Zfp804a (Figure 3(a)) indicating that,
in this particular in vitro system, expression of Zfp804a
was positively regulated by Hoxc8. To prove in vivo, we
analyzed levels of Hoxc8 and Zfp804a mRNA transcripts
along the A-P axis of E11.5 embryos. From Figure 3(b),
Hoxc8 was expressed in the trunk area (regions 3 to 5)
except in head whereas Zfp804a mRNA was seen generally
through-out the trunk with only a residual signal in the
head area (Figure 3(b)) [23]. Thus, the expression patterns
on Zfp804a correlate to some extent with that of Hoxc8 in
this developmental stage. Since the regulation target genes by
Hox is complex and multifactorial [24, 25], we are cautious
in interpreting such data since Hox regulates its target in a
context-dependent manner and proves to be both a repressor
and activator at the same time [26].
An interesting twist in the relationship of Hoxc8-
Zfp804a regulation lies in the recent discovery that its
human homologue, ZNF804A, turns out to be a marker
for schizophrenia and bipolar disorders [27]. Although
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Table 1: Candidate downstream targets of Hoxc8 from ChIP-cloning. Referred to Chung HJ et al. [10].
ACCN no. Gene name
No. of
Hox-binding
motifs
Chromosome Location Molecular/cellular function
NM 175513 zinc finger protein 804A 75 2 intron 1 zinc ion binding; metal ion binding
NM 001085495
ADP-ribosylation factor
guanine nucleotide-exchange
factor 2 (brefeldinA-inhibited)
22 2 intron 1
ARF guanyl-nucleotide exchange
factor activity; binding; myosin
binding; exocytosis; intracellular
signaling cascade; regulation of
ARF protein signal transduction
NW 001030820 118.3 kb at 5
′ side:
hypothetical protein
unknown
20 6
intergenic
region
XM 920612.2
22 kb at 3′ side: Similar to
lanin A-related sequence 1
protein isoform 2
unknown
NM 028533.2 47 kb at 5
′ side: hypothetical
protein LOC 73410
unknown
20 9
intergenic
region
NM 011916.2 50 kb at 3
′ side: 5′-3′
exoribonuclease 1
5′-3′ exonuclease and hydrolase
activities
NM 080788.3 tau tubulin kinase 2 isoform
1,2
16 2 intron 10
nucleotide binding; protein
serine/threonine kinase activity;
ATP binding; transferase activity
NM 153386.2 Usher syndrome 3A homolg
isoform 1,2
13 3 intron 1
sensory perception of sound;
photoreceptor cell maintenance;
equilibrioception
NM 172964.3 134 kb at 5
′ side: Rho GTPase
activating protein 28
GTPase activator activity
11 17
intergenic
region
NM 177278.3 221 kb at 3
′ side: hypothetical
protein LOC320858
unknown
NM 172825.2 G protein-coupled receptor
128
10 16 intron 4
neuropeptide signaling pathway;
G-protein coupled receptor activity
NM 001083919.1
139 kb at 5′ side:
Cardiomyopathy associated 3
isoform 2
unknown
10 2
intergenic
region
NM 020283.2
459 kb at 3′ side:
UDP-Gal:βGlcNAc
β1,3-galatosyl transferase
protein amino acid glycosylation;
oligosaccharide biosynthetic
process; lipid glycosylation
NM 013600 mutS homolog 5 8 17 intron 11
nucleotide binding; DNA binding;
protein binding; ATP binding;
mismatched DNA binding;
NF-kappaB binding
NM 008960.2 phosphatase and tensin
homolog
4 19 intron 5
phosphatidylinositol-3-
phosphatase activity; protein
serine/threonine phosphatase
activity; PDZ domain binding
NM 011796.2 calpain 10 0 1
intron
5/exon 6
SNARE binding;
calcium-dependent cysteine-type
endopeptidase activity; cytoskeletal
protein binding; peptidase activity
Journal of Biomedicine and Biotechnology 5
GAAACTGGTATCCAACAAAATTGTATCTTATACGTATAGACCTGAAAACCTTCATCTCTGTTACAACAGTTACAGTAGAACTATAAA
GAGGTTGTAAATTTATGGTCTCTGTGAGAACGTTAAGTACAAAAAGAGTGATATAACGAACTTCAATTCCGAAAAAAAAGTAGTAGAGTTTACTAA
TTTTCAAACTTTTGAGTTGTAAACTTTGTTTAGTTCGTCTAAACCAACACT
CGTCCCTTAAAACCCGATATCTGATGATAGTAAATCATGATACACACCTTTGTAAAAACAAAGTGTGTGA
TACCTTAAGTCCAGTCACGGAAAAGATAAGGTGAAAGAATCTAAGTAACCATATCGTTACACTTTTCTATGATAAA
TATAAGCGAAGTTTTTAAGAAAGACTTGAGTGATCAATCATCTTGTTTTAGTATCCATGATAAGTCGTCCTCAGACTCGA
CACTCAGAACTCCGTGTTATAAAGAATTTCTTTGTACGAGTGTCTTGTGTCCTTATTTCTTGTAAAAGT
ACGTACTCAAAAACAAACATGTACACCAACTTCCTGATAAGTGTATCCTGAAATCCGAAAACAAGCACTATGGAGTGTCTCTATCGATTTGA
 GATTTTCACCCTACAAACGATGGCGGATCTCTTCTTCTTAT
AATATATTAATTA
AATA
TAATTAATAATAATAATAATAATAATAATAATAATAATAATAATAAATA
TAATAATATATTAATATATTATTAATTATT
TAATTAATTAAATATATTATATTA
TTATTATATTAATATTAATA
TATTAATATAATTATTATAATTATTTAATTA
AATATATT
TAAT (845 bp)
NC 000068.6Zfp 804a gene construct
NM 175513.3
5′
[81893815
Coding region Untranslated region
(107928-108319) [82100036
3′
NP 780722.2 CCDS38160.1
(Chr. 2; intron1)
206 kb
180 kb
100 kb
(a)
In
pu
t
N
o
A
b.
Ig
G
H
ox
c8
A
b.
F9 cell
E11.5 embryo
(b)
R
el
at
iv
e
lu
ci
fe
ra
se
ac
ti
vi
ty
0
2
4
6
8
10
pGL3MP pGL3MP-Zfp804a
pGL3MP
pGL3MP: Zfp804a
pcDNA3
pcDNA3: Hoxc8
siHoxc8
+ + +
− − −
+ − −
− + +
− − +
− − −
+ + +
+ − −
− + +
− − +
pcDNA
Hoxc8
siHoxc8
(c)
Figure 2: The mouse Zfp804a gene is located in chromosome 2 and has Hoxc8 responsive elements in the intron1 region. (a) Zfp804a
gene organization. Coding regions or exons (black box) and the introns (grey box) are shown. Hoxc8-binding core sequences are shown
in bold and the underlined sequences indicate primer targets for ChIP-PCR. (b) A ChIP experiment was performed using mouse E11.5
embryos and F9 cell line. The DNA-Hoxc8 complexes were immunoprecipitated by a Hoxc8-monoclonal antibody (lane 4). Input (prior
to immunoprecipitation) was used for an internal control (lane 1), and mouse IgG and vehicle were used as a negative control (lane 3-4).
(c) Hoxc8 activates Zfp804a in the eﬀector-reporter assay. Luciferase construct is driven by a minimal promoter fused to the intronic segment
of Zfp804a (pGL3-MP : Zfp804a; reporter) and cotransfected with a empty vector pcDNA3, pcDNA3:Hoxc8 (eﬀector), and a siRNA for
Hoxc8 in F9 cells. Thirty-six hours after transfection, luciferase activities were measured. The experiments were performed in 3 independent
trials. The mean values of the luciferase activity are shown as fold change relative over that of the pcDNA3.
ZNF804A is uncharacterized and its functions are still
unknown to date, it is interesting that fMRI images of
ZNF804A SNPs carriers show altered functional coupling
between the dorsolateral prefrontal cortex (DLPFC) and the
hippocampus [28]. Since genetic variation in dopaminergic
and glutaminergic neurotransmission aﬀects DLPFC or
hippocampus connectivity, the examination of ZNF804A
and HOXC8 in these neurotransmitter cascades would be
interesting in the future. During embryogenesis, Hox gene
expression is activated prior to rhombomeric segmentation,
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Figure 3: RT-PCR analysis of the Zfp804a gene expression in vitro and in vivo. Total cellular RNA was isolated (a) in vitro with F9 cells
transfected with pcDNA3 vector (control) and Hoxc8 overexpression vector and (b) in vivo, from mouse E11.5 embryos. (c) Total cellular
RNA was isolated from mouse adult whole brain, cortex, and hippocampus (males, 6 weeks old). (d) A ChIP experiment was performed
using mouse adult whole brain, cortex, and hippocampus. The DNA-Hoxc8 complexes were immunoprecipitated by a Hoxc8 monoclonal
antibody (lane 2). Input (prior to immunoprecipitation) was used for an internal control (lane 1), and mouse IgG and vehicle were used as
a negative control (lane 3-4) and DW (lane 5).
and its anterior boundaries, limited to those in the paralogue
groups I–IV, are found only in the neuroepithelia that give
rise to the hindbrain [29]. Because of this bias, no systematic
study on neurobiology of the other Hox paralogues has been
done. Therefore, the finding here is rather surprising and
very intriguing.
Recently, some HOX genes have been reported to be
expressed in adult cells, and misexpression of certain HOX
gene(s) can lead to diseases such as cancer [30]. Therefore
we examined the expression of Hoxc8 in adult mouse brain.
As shown in Figure 3(c), we were also able to verify the
expression of Hoxc8 in adult normal brain tissue, cortex, and
hippocampus by RT-PCR. Interestingly, Zfp804a was only
detected in cortex, but not in hippocampus. Consistent with
this expression patterns, Hoxc8 showed a prominent binding
to Zfp804a in cortex as well as whole brain (Figure 3(d)).
Given that Hox genes are master transcription factors at
the apex of the genetic hierarchy of developmental control, it
is tantalizing to regard that their “fetal” molecular networks
would extend influence to adulthood and more so, in such
complex systems, such as psychosis. A future challenge from
our work is to elucidate the molecular mechanisms respon-
sible for this phenomenon and the potential implications of
Hox regulatory control in human behavior.
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